221 related articles for article (PubMed ID: 24692704)
1. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
2. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
3. Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.
Csonka Á; Spengler G; Martins A; Ocsovszki I; Christensen JB; Hendricks O; Kristiansen JE; Amaral L; Molnar J
In Vivo; 2013; 27(6):815-20. PubMed ID: 24292587
[TBL] [Abstract][Full Text] [Related]
4. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
Csonka Á; Hamdoun S; Spengler G; Martins A; Vincze I; Efferth T; Molnár J
Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the effect of multidrug resistance modifiers on prostate cancer, mouse lymphoma and colon cancer cells].
Csonka Á
Orv Hetil; 2016 Sep; 157(37):1489-95. PubMed ID: 27615200
[TBL] [Abstract][Full Text] [Related]
6. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
7. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
8. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
9. Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein.
Spengler G; Molnar J; Viveiros M; Amaral L
Anticancer Res; 2011 Dec; 31(12):4201-5. PubMed ID: 22199281
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
11. Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells.
Matos AM; Reis M; Duarte N; Spengler G; Molnár J; Ferreira MJ
J Nat Prod; 2015 Sep; 78(9):2215-28. PubMed ID: 26331763
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
13. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
14. Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer.
GajdÁcs M; NovÉ M; Csonka Á; Varga B; SanmartÍn C; DomÍnguez-Álvarez E; Spengler G
Anticancer Res; 2020 Sep; 40(9):4921-4928. PubMed ID: 32878780
[TBL] [Abstract][Full Text] [Related]
15. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
Spengler G; Kincses A; Rácz B; Varga B; Watanabe G; Saijo R; Sekiya H; Tamai E; Maki J; Molnár J; Kawase M
Anticancer Res; 2018 Nov; 38(11):6181-6187. PubMed ID: 30396935
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
Spengler G; Ocsovszki I; Tönki ÁS; Saijo R; Watanabe G; Kawase M; Molnár J
Anticancer Res; 2015 Nov; 35(11):5915-9. PubMed ID: 26504015
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
[TBL] [Abstract][Full Text] [Related]
19.
Bourichi S; Misbahi H; Rodi YK; Chahdi FO; Essassi EM; Szabó S; Szalontai B; Gajdács M; Molnár J; Spengler G
Anticancer Res; 2018 Jul; 38(7):3999-4003. PubMed ID: 29970523
[TBL] [Abstract][Full Text] [Related]
20. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
